Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-arginine in Essential Hypertension
NCT00137124Phase 3Completed
- Sponsor
- FAU Erlangen-Nürnberg Medical Faculty
- Start
- May 2006
- Primary completion
- Dec 2009
- Modality
- Peptides, Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of arginine in essential hypertension, sponsored by FAU Erlangen-Nürnberg Medical Faculty. Started May 2006; status: completed.
02
Drugs
arginine
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT00137124.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00137124.